Interface Fund
VC Fund
Interface Fund is a VC fund focused on Biotechnology and Medical. Pre-seed and seed stage investing in deep tech, emphasizing neural interfaces and new computing platforms
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Interface Fund invests in
Stages Interface Fund invests in
Countries Interface Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Julia Prakapovich
|
|||
Investment Focus
Industry
- Biotechnology 2 (50%)
- Medical 1 (25%)
- Software 1 (25%)
- Biopharma 1 (25%)
- Health Care 1 (25%)
Stage
- Seed 2 (50%)
- Pre-Seed 2 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Julia Prakapovich
Managing Partner; General Partner
|
Managing Partner; General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Merge Labs
|
Merge Labs provides a unified application programming interface that enables software companies to connect with multiple third-party platforms through a single integration. The company’s products support integrations across categories such as accounting, customer relationship management, human resources, ticketing, and payments. Its platformhandles data normalization, authentication, sync scheduling, and error handling to reduce the effort required to build and maintain integrations. Merge Labs also offers tools for monitoring data syncs, managing permissions, and controlling access across connected systems. The service is designed for engineering and product teams that need to scale integrations while maintaining consistent data flows between applications. | $252M / Seed / Jan 15, 2026 | |
Motif Neurotech
|
Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses. | $2M / Seed / Feb 28, 2023 | |
MK1
|
MK1 specializes in building dependable AI for organizations, incorporating technologies such as proprietary large language models (LLMs) optimized for effectively processing huge documents, reducing hallucinations, improving agent memory, and lowering token costs. | Pre-Seed / Feb 01, 2023 | |
Cache
|
Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again. | Pre-Seed / Apr 05, 2022 |
Co-Investors
One Mind Accelerator
2 deals together
Bain Capital
1 deal together
Divergent Capital
1 deal together
Empath Ventures
1 deal together
OpenAI
1 deal together
PsyMed Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Interface Fund invest in?
Interface Fund invests primarily in Biotechnology, Medical and Software startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Interface Fund?
Public channels for Interface Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Interface Fund?
The team at Interface Fund includes Julia Prakapovich (Managing Partner; General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
